Stem cell factor affects tumour progression markers in metastatic melanoma cells
Francesca Prignano(University of Florence), Silvia Moretti(University of Insubria), Gianni Gerlini(Tumour Institute of Tuscany), Benedetta Salvatori(University of Florence), Nicola Pimpinelli(University of Florence), Sandra Mazzoli(Ospedale Santa Maria Annunziata), Claudio Orlando(University of Messina)
Cited by 11
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
|European Journal of Cancer|2017|449
Guidelines for the management of vitiligo: the European Dermatology Forum consensus
|British Journal of Dermatology|2012|446